Effects of carbamazepine on serum levels of folic acid and homocysteine

Pan Arab Journal of Neurosurgery

Volumn 14, Issue 1, 2010, Pages

  Hasan, Khaled ^a   Saleh, Yaser ^b   Assaad, Fawaz ^b  

^a DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^b Assad University Hospital   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID METABOLISM; ANTICONVULSANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MONOTHERAPY; OUTPATIENT; TREATMENT RESPONSE;

EID: 77952148785     PISSN: 13196995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Apeland T, Mansoor MA, Strandjord RE: Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res 2001, 47(1): 27-35 (Pubitemid 32973645)
2. Bleich S, Degner D, Bandelow B, von Ahsen N, Ruther E, Komhuber J: Plasma homocysteine is a predictor of alcohol withdrawal seizures. Neuroreport 2000, 21(11): 2749-2752 (Pubitemid 30604024)
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274(13): 1049-1057
4. Chambers JC, Seddon MD, Shah S, Keener JS: Homocysteine - a novd risk factor for vascular disease. J R Soc Med 2001, 94(1): 10-13 (Pubitemid 32116138)
5. Eikelboom JW, Lonn E, Genest J Jr, Hankey GJ, Yusuf S: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131(5): 363-375 (Pubitemid 29424631)
6. Hankey GJ, Eikelenboom JW: Homocysteine and vascular disease. Lancet 1999, 354: 407-413
7. Karabiber H, Sonmezgoz E, Ozerol E, Yakinci C, Otlu B, Yologlu S: Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 2003, 25(2): 113-115 (Pubitemid 36170307)
8. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM: Maternal plasma fdate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993, 86: 703-708 (Pubitemid 2001377)
9. McCully KS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969, 56(1): 111-128
10. Ono H, Sakamoto A, Eguchi T, Fujita N, Nomura S, Ueda H, et al: Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabdism 1997, 46(8): 959-962 (Pubitemid 27339924)
11. Selhub J, D'Angelo G: Hyperhomocysteinemia and thrombosis: acquired conditions. Thromb Haemost 1997, 78(1): 527-531
12. Tamura T, Aiso K, Johnston KE, Black L, Faught E: Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res 2000, 40(1): 7-15 (Pubitemid 30193357)
13. Verrotrj A, Pascarella R, Trotta D, Giuva T, Morgese G, Chiarelli F: Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res 2000, 41(3): 253-257 (Pubitemid 30658048)
14. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998, 338(15): 1042-1050
15. Yoo JH, Hong SB: A common mutation in the methylene-tetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism 1999, 48(8): 1047-1051